Brief: Exelixis Says Cabometyx Reduces Risk Of Progression Or Death By 74% In Non-Functional Net, 60% In Functional Net
BRIEF-Exelixis Says Cabometyx Reduces Risk Of Progression Or Death By 74% In Non-Functional Net, 60% In Functional Net May 30 (Reuters) - Exelixis Inc EXEL.O:
EXELIXIS - CABOMETYX REDUCES RISK OF PROGRESSION OR DEATH BY 74% IN NON-FUNCTIONAL NET, 60% IN FUNCTIONAL NET
Source text: ID:nBw6fbBPFa
Further company coverage: EXEL.O
((Reuters.Briefs@thomsonreuters.com;))